Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.
about
Outstanding animal studies in allergy II. From atopic barrier and microbiome to allergen-specific immunotherapyMolecular aspects of allergens in atopic dermatitisSynchronous Immune Alterations Mirror Clinical Response During Allergen Immunotherapy.AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer.Elevated serum adipsin may predict unsuccessful treatment for cows' milk allergy but other biomarkers do not.Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model.Immune monitoring for precision medicine in allergy and asthma.Perspectives in allergen immunotherapy: 2017 and beyond.EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy.The Use of Biomarkers to Predict Aero-Allergen and Food Immunotherapy Responses.Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling.The future outlook on allergen immunotherapy in children: 2018 and beyond.Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot studyDoes clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AITImmunotherapy and Asthma in Children
P2860
Q33655749-5E3AF5A0-D900-4574-A37D-863EF1497D7CQ39378515-8256DD46-3E8F-4705-A847-B765DC351B90Q45072722-8125D6A8-E388-4010-97BC-9BF0721BBF62Q46132734-BC0FFFED-FD4A-492E-B724-707CAFED886EQ47244230-3324356C-1B1D-458A-B76B-4B7B2912FCE6Q47437171-A05C63A8-7A9A-4CFE-B744-CBB108297388Q47569343-CD44E072-EBC7-4B4A-9003-0C840DAF6C3CQ47700986-DD9C7EEF-5168-4B97-8EBF-A03B2BC709CEQ47764778-3E4C46AF-4867-4B82-9C73-C0521D2C1498Q48247434-DBBBA6AB-5E14-4282-94A5-D937C46E06FDQ49891958-B94B7C62-7615-40BB-8095-562A80150C55Q52625055-17362ED3-27D6-4AE5-B67F-60EEBA047C26Q55662210-8E1E34B2-ADA3-421B-A3ED-116C54CD5088Q57489440-729E36FB-8FF9-49C7-827D-86B4E9E2EEA3Q58580218-B7B64436-5C1B-474B-B8E0-F36AC19000BBQ58729387-3559963E-26F1-480E-A306-738CF424A350
P2860
Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Biomarkers for monitoring clin ...... thma: an EAACI Position Paper.
@en
Biomarkers for monitoring clin ...... thma: an EAACI Position Paper.
@nl
type
label
Biomarkers for monitoring clin ...... thma: an EAACI Position Paper.
@en
Biomarkers for monitoring clin ...... thma: an EAACI Position Paper.
@nl
prefLabel
Biomarkers for monitoring clin ...... thma: an EAACI Position Paper.
@en
Biomarkers for monitoring clin ...... thma: an EAACI Position Paper.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Biomarkers for monitoring clin ...... sthma: an EAACI Position Paper
@en
P2093
A M Chaker
J H Kappen
J Kleine-Tebbe
L Jacobsen
L K Poulsen
M A Calderon
S R Durham
P2860
P304
P356
10.1111/ALL.13138
P50
P577
2017-04-06T00:00:00Z